These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10526400)

  • 1. Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7.
    Yoh M; Frimpong EK; Voravuthikunchai SP; Honda T
    Can J Microbiol; 1999 Sep; 45(9):732-9. PubMed ID: 10526400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro antibacterial activity of faropenem, a novel oral penem antibiotic, against enterohemorrhagic Escherichia coli O157 strains].
    Nasu T; Okamoto K; Nakanishi T; Nishino T
    Jpn J Antibiot; 1999 Aug; 52(8):541-53. PubMed ID: 10587879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antimicrobial agents, especially fosfomycin, on the production and release of Vero toxin by enterohaemorrhagic Escherichia coli O157:H7.
    Yoh M; Frimpong EK; Honda T
    FEMS Immunol Med Microbiol; 1997 Sep; 19(1):57-64. PubMed ID: 9322069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of antibiotics used for enterohemorrhagic Escherichia coli O157 enteritis--effect of various antibiotics on extracellular release of verotoxin].
    Ito T; Akino E; Hiramatsu K
    Kansenshogaku Zasshi; 1997 Feb; 71(2):130-5. PubMed ID: 9077070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Suppressive effect of clarithromycin on the production of verotoxin by E. coli O157].
    Nakata K; Tozu T; Hoshikawa Y; Sakai A; Tanaka N; Akashi T; Kanegasaki S
    Kansenshogaku Zasshi; 1997 May; 71(5):437-42. PubMed ID: 9209125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobials effective for inhibition of enterohaemorrhagic Escherichia coli strains O26, O111, and O157 and their effects on Shiga toxin releases.
    Lee JH; Stein BD
    J Microbiol Biotechnol; 2009 Oct; 19(10):1238-43. PubMed ID: 19884786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
    Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J
    Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
    Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of subinhibitory concentrations of antimicrobial agents on Escherichia coli O157:H7 Shiga toxin release and role of the SOS response.
    Nassar FJ; Rahal EA; Sabra A; Matar GM
    Foodborne Pathog Dis; 2013 Sep; 10(9):805-12. PubMed ID: 23808851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents.
    Grif K; Dierich MP; Karch H; Allerberger F
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):761-6. PubMed ID: 9923515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stimulating effect of fosfomycin, an antibiotic in common use in Japan, on the production/release of verotoxin-1 from enterohaemorrhagic Escherichia coli O157:H7 in vitro.
    Yoh M; Honda T
    Epidemiol Infect; 1997 Aug; 119(1):101-3. PubMed ID: 9287950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of in-vitro activity of new quinolones, macrolides, and minocycline against Mycoplasma pneumoniae.
    Ikejima H; Yamamoto H; Ishida K; Kaku M; Shimada J
    J Infect Chemother; 2000 Sep; 6(3):148-50. PubMed ID: 11810555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and analysis of spices with ability to suppress verocytotoxin production by Escherichia coli O157.
    Takemasa N; Ohnishi S; Tsuji M; Shikata T; Yokoigawa K
    J Food Sci; 2009 Oct; 74(8):M461-6. PubMed ID: 19799674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory effects of macrolide antibiotics at low concentrations on vero toxin production by pathogenic E. coli O157].
    Nakada M; Totsu T; Tanaka N; Akashi T; Kanegasaki S
    Jpn J Antibiot; 1998 Jan; 51 Suppl A():146-50. PubMed ID: 9597511
    [No Abstract]   [Full Text] [Related]  

  • 15. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells.
    Devenish J; Gyles C; LaMarre J
    Can J Microbiol; 1998 Jan; 44(1):28-34. PubMed ID: 9522446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice.
    Zhang X; McDaniel AD; Wolf LE; Keusch GT; Waldor MK; Acheson DW
    J Infect Dis; 2000 Feb; 181(2):664-70. PubMed ID: 10669353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics and molecular biology of verotoxin produced by enterohemorrhagic Escherichia coli].
    Iijima Y; Honda T
    Nihon Rinsho; 1997 Mar; 55(3):646-50. PubMed ID: 9086774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
    Stout JE; Sens K; Mietzner S; Obman A; Yu VL
    Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activity of bicozamycin against Escherichia coli O157:H7 producing Vero toxin].
    Matsumoto Y
    Nihon Saikingaku Zasshi; 2001; 56(2):455-63. PubMed ID: 11431931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrolides and clindamycin suppress the release of Shiga-like toxins from Escherichia coli O157:H7 in vitro.
    Murakami J; Kishi K; Hirai K; Hiramatsu K; Yamasaki T; Nasu M
    Int J Antimicrob Agents; 2000 Jul; 15(2):103-9. PubMed ID: 10854805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.